The future of personalized medicine depends on affordable DNA sequencing. In the race for the $1,000 genome, several sequencer manufacturers are working on making equipment that can sequence DNA and RNA faster and more accurately. But so far, only one company — San Diego, California-based Illumina — has US FDA regulatory approval to use its […]

The post The Ins & Outs of Illumina Sequencing appeared first on Bitesize Bio.